The role of the Foundation’s Scientific Medical Advisory Board (SMAB) is to advise the Board of Directors on a range of issues. In general, the SMAB provides scientific review of research proposals to ensure that the research programs funded by the INADcure Foundation are scientifically sound, pertinent and have potential to make an impact within the INAD research community. Our Scientific Medical Advisory Board is made up of scientists, researchers and clinicians from around the country.
Co-Chairs
Hugo J Bellen, D.V.M., Ph.D.
Baylor College of Medicine, Houston, TX
Professor, Neuroscience, Genetics
HHMI Investigator
Learn more: Bellen Lab
Elizabeth Schwarzbach, Ph.D.
BigHat Biosciences, San Carlos, CA (NYC)
Chief Business Officer
Members
Alexandra Grella, Ph.D.
Sanofi-Aventis
Senior Scientist
Cell Therapy process development
Christopher B. Eckman, PhD
Biomedical Research Institute of New Jersey, Morristown, NJ
Professor of Biomedical Sciences
Darius John Adams, MD
Atlantic Health System, Morristown, NJ
Clinical and Biochemical Geneticist
Gilbert Di Paolo, PhD
Denali Therapeutics, San Francisco, CA
Senior Director and Staff Scientist
Guang Lin, Ph.D.
Baylor College of Medicine, Houston, TX
Postdoctoral Associate
Molecular and Human Genetics
Nick France
EscapeBio, San Francisco, CA (NJ)
Vice President
Clinical Research
Dr. Paul Kotzbauer, MD, PhD
Washington University School of Medicine, St. Louis, MO
Associate Professor of Neurology
Learn More: Kotzbauer Lab
Rubin Modi, PharmD
Bristol Myers Squibb
Associate Director
Global Regulatory Team Leader
Chan Zuckerberg Initiative Rare As One Scientific Advisors
Clement Y. Chow, Ph.D.
University of Utah School of Medicine
Associate Professor
Human Genetics
Learn More: The Chow Lab
Erica A. Dale, Ph.D.
University of Florida
College of Medicine
Assistant Professor
Department of Physiology and Functional Genomics
Learn More: Dale Lab